Sari-Ak, D.; Con, F.; Helvaci, N.; Yelkenci, H.E.; Kural, A.; Can, O.; Beker, M.C.
Exploring the Proteomic Signature of Diabetic Nephropathy: Implications for Early Diagnosis and Treatment. Life 2025, 15, 1312.
https://doi.org/10.3390/life15081312
AMA Style
Sari-Ak D, Con F, Helvaci N, Yelkenci HE, Kural A, Can O, Beker MC.
Exploring the Proteomic Signature of Diabetic Nephropathy: Implications for Early Diagnosis and Treatment. Life. 2025; 15(8):1312.
https://doi.org/10.3390/life15081312
Chicago/Turabian Style
Sari-Ak, Duygu, Fatih Con, Nazli Helvaci, Hayriye Ecem Yelkenci, Alev Kural, Ozgur Can, and Mustafa Caglar Beker.
2025. "Exploring the Proteomic Signature of Diabetic Nephropathy: Implications for Early Diagnosis and Treatment" Life 15, no. 8: 1312.
https://doi.org/10.3390/life15081312
APA Style
Sari-Ak, D., Con, F., Helvaci, N., Yelkenci, H. E., Kural, A., Can, O., & Beker, M. C.
(2025). Exploring the Proteomic Signature of Diabetic Nephropathy: Implications for Early Diagnosis and Treatment. Life, 15(8), 1312.
https://doi.org/10.3390/life15081312